Kinney Horn

Companies

• Immunome Inc.CHIEF BUSINESS OFFICER Feb 21, 2024 to now¹
• Olema Pharmaceuticals, Inc.Chief Business Officer Nov 18, 2020 to Feb 2, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OPOlema Pharmaceuticals, Inc. OLMA2,458 shares³$17.5K at $7.11Mar 10, 2022
• IImmunome Inc. IMNM0 shares⁴Aug 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 4, 2026Sold 90,616 shares at $25.09 of Immunome Inc.⁴
• Aug 4, 2026Exercised options 40,250 shares at $10.60 of Immunome Inc.⁴
• Aug 4, 2026Exercised options 50,366 shares at $12.92 of Immunome Inc.⁴
• Jul 23, 2026Granted 31,250 shares of Immunome Inc.⁵
• Jul 7, 2026Sold 1,092 shares at $25.00 of Immunome Inc.⁶
• Jul 7, 2026Exercised options 1,092 shares at $12.92 of Immunome Inc.⁶
• Mar 10, 2022Sold 5,253 shares at $4.75 of Olema Pharmaceuticals, Inc.³
• Mar 10, 2022Exercised options 5,253 shares at $2.06 of Olema Pharmaceuticals, Inc.³
• Feb 10, 2022Returned to company 5,251 shares of Olema Pharmaceuticals, Inc.⁷
• Feb 10, 2022Exercised options 5,251 shares at $2.06 of Olema Pharmaceuticals, Inc.⁷
• Jan 10, 2022Sold 5,251 shares at $6.85 of Olema Pharmaceuticals, Inc.⁸
• Jan 10, 2022Exercised options 5,251 shares at $2.06 of Olema Pharmaceuticals, Inc.⁸
• Dec 10, 2021Sold 5,251 shares at $10.39 of Olema Pharmaceuticals, Inc.⁹
• Dec 10, 2021Exercised options 5,251 shares at $2.06 of Olema Pharmaceuticals, Inc.⁹
• Nov 10, 2021Sold 27,668 shares at $26.88 of Olema Pharmaceuticals, Inc.¹⁰
• Nov 10, 2021Exercised options 22,417 shares at $19.00 of Olema Pharmaceuticals, Inc.¹⁰
• Nov 10, 2021Exercised options 5,251 shares at $2.06 of Olema Pharmaceuticals, Inc.¹⁰
• Oct 11, 2021Sold 3,146 shares at $28.19 of Olema Pharmaceuticals, Inc.¹¹
• Oct 11, 2021Sold 2,105 shares at $27.47 of Olema Pharmaceuticals, Inc.¹¹
• Oct 11, 2021Exercised options 5,251 shares at $2.06 of Olema Pharmaceuticals, Inc.¹¹